https://orcid.org/0000-0002-2740-5257
Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bo Wang, Wei Shen, Li Yan, Xiaoyu Li, Linlei Zhang, Suyuan Zhao & Xiao Jin. (2023) Reveal the potential molecular mechanism of circRNA regulating immune-related mRNA through sponge miRNA in the occurrence and immune regulation of papillary thyroid cancer. Annals of Medicine 55:2.
Read now
Read now
Xiao-jie Sun, Le Ai & Yang-chun Feng. (2020) The Value of ABO Blood Group and Complete Blood Count for the Prognosis Analysis of Gastric Cancer Patients. OncoTargets and Therapy 13, pages 4627-4633.
Read now
Read now
Articles from other publishers (15)
Yuanhui Li, Fan Wu, Weigang Ge, Yu Zhang, Yifan Hu, Lingqian Zhao, Wanglong Gou, Jingjing Shi, Yeqin Ni, Lu Li, Wenxin Fu, Xiangfeng Lin, Yunxian Yu, Zhijiang Han, Chuanghua Chen, Rujun Xu, Shirong Zhang, Li Zhou, Gang Pan, You Peng, Linlin Mao, Tianhan Zhou, Jusheng Zheng, Haitao Zheng, Yaoting Sun, Tiannan Guo & Dingcun Luo. (2024) Risk stratification of papillary thyroid cancers using multidimensional machine learning. International Journal of Surgery 110:1, pages 372-384.
Crossref
Crossref
Lingqian Zhao, Tao Hu, Yuan Cai, Tianhan Zhou, Wenhao Zhang, Fan Wu, Yu Zhang & Dingcun Luo. (2023) Preoperative risk stratification for patients with ≤ 1 cm papillary thyroid carcinomas based on preoperative blood inflammatory markers: construction of a dynamic predictive model. Frontiers in Endocrinology 14.
Crossref
Crossref
Elena Russo, Mathilda Guizzardi, Luca Canali, Francesca Gaino, Andrea Costantino, Gherardo Mazziotti, Andrea Lania, Silvia Uccella, Luca Di Tommaso, Fabio Ferreli, Luca Malvezzi, Giuseppe Spriano & Giuseppe Mercante. (2023) Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis. Reviews in Endocrine and Metabolic Disorders 24:6, pages 1205-1216.
Crossref
Crossref
Guoqiang Wang, Yahui Ma, Yixiang Liu, Yuzhu Fan, Xiang Miao, Yiqi Zhang & Hongbo Zhu. (2023) Predictive value of systemic inflammatory markers for recurrence of papillary thyroid cancer. Journal of Surgical Oncology 128:5, pages 743-748.
Crossref
Crossref
Nerina Denaro, Rebecca Romanò, Salvatore Alfieri, Alessia Dolci, Lisa Licitra, Imperia Nuzzolese, Michele Ghidini, Claudia Bareggi, Valentina Bertaglia, Cinzia Solinas & Ornella Garrone. (2023) The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer. Cancers 15:9, pages 2458.
Crossref
Crossref
Claudio Gambardella, Federico Maria Mongardini, Maddalena Paolicelli, Davide Bentivoglio, Giovanni Cozzolino, Roberto Ruggiero, Alessandra Pizza, Salvatore Tolone, Gianmattia del Genio, Simona Parisi, Luigi Brusciano, Loredana Cerbara, Ludovico Docimo & Francesco Saverio Lucido. (2023) Role of Inflammatory Biomarkers (NLR, LMR, PLR) in the Prognostication of Malignancy in Indeterminate Thyroid Nodules. International Journal of Molecular Sciences 24:7, pages 6466.
Crossref
Crossref
Yingying Hu, Yanyan Shen, Erjie Xia, Suzita Hirachan, Adheesh Bhandari & Zao Jin. (2023) Monocyte-to-High-Density Lipoprotein Cholesterol Ratio Together With the Lymphocyte-to-Monocyte Ratio in Predicting the Malignancy of the Thyroid Nodule in Patients Complicated With Type 2 Diabetes. Clinical Medicine Insights: Oncology 17.
Crossref
Crossref
Daniel Deme, Sandor Kovacs & Andras Telekes. (2022) Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination. Pathology and Oncology Research 28.
Crossref
Crossref
Chiara Offi, Roberto Maria Romano, Angelo Cangiano, Marcello Filograna Pignatelli, Giancarlo Candela & Giovanni Docimo. (2021) Evaluation of LMR, NLR and PLR as predictors of malignancy in indeterminate thyroid nodulesValutazione di LMR, NLR e PLR come predittori di malignità in noduli tiroidei indeterminati. Acta Otorhinolaryngologica Italica 41:6, pages 530-536.
Crossref
Crossref
Hongzhi Xu, Yufeng Pang, Xueqing Li, Bingbing Zha, Tao He & Heyuan Ding. (2021) Monocyte to high‐density lipoprotein cholesterol ratio as an independent risk factor for papillary thyroid carcinoma. Journal of Clinical Laboratory Analysis 35:11.
Crossref
Crossref
Pedro Marques, Friso de Vries, Olaf M Dekkers, Márta Korbonits, Nienke R Biermasz & Alberto M Pereira. (2021) Serum Inflammation-based Scores in Endocrine Tumors. The Journal of Clinical Endocrinology & Metabolism 106:10, pages e3796-e3819.
Crossref
Crossref
Cínthia Minatel Riguetto, Icléia Siqueira Barreto, Frederico Fernandes Ribeiro Maia, Lígia Vera Montali da Assumpção & Denise Engelbrecht Zantut-Wittmann. (2021) Usefulness of pre-thyroidectomy neutrophil–lymphocyte, platelet–lymphocyte, and monocyte–lymphocyte ratios for discriminating lymph node and distant metastases in differentiated thyroid cancer. Clinics 76, pages e3022.
Crossref
Crossref
Chunyan Zhou, Dong Duan & Shuang Liu. (2021) Predictive Value of a Prognostic Model Based on Lymphocyte-to-Monocyte Ratio Before Radioiodine Therapy for Recurrence of Papillary Thyroid Carcinoma. Technology in Cancer Research & Treatment 20, pages 153303382110279.
Crossref
Crossref
Keunyoung Kim, Kyoungjune Pak, In-Joo Kim, Mijin Kim, Bo Hyun Kim, Byung-Joo Lee & Seong-Jang Kim. (2020) Lymphocyte-to-monocyte ratio prior to radioiodine ablation in low- and intermediate-risk, papillary thyroid cancer. Endocrine 70:2, pages 364-371.
Crossref
Crossref
Haruhiko Yamazaki, Kiminori Sugino, Kenichi Matsuzu, Chie Masaki, Junko Akaishi, Kiyomi Hames, Chisato Tomoda, Akifumi Suzuki, Takashi Uruno, Keiko Ohkuwa, Wataru Kitagawa, Mitsuji Nagahama, Munetaka Masuda & Koichi Ito. (2020) Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in anaplastic thyroid carcinoma. Endocrine 70:1, pages 115-122.
Crossref
Crossref